Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0C4VX
|
||||
Former ID |
DNC007265
|
||||
Drug Name |
4-(7-chloro-1-propyl-1H-indazol-3-yl)phenol
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [527327] | ||
Structure |
Download2D MOL |
||||
Formula |
C16H15ClN2O
|
||||
Canonical SMILES |
CCCN1C2=C(C=CC=C2Cl)C(=C3C=CC(=O)C=C3)N1
|
||||
InChI |
1S/C16H15ClN2O/c1-2-10-19-16-13(4-3-5-14(16)17)15(18-19)11-6-8-12(20)9-7-11/h3-9,18H,2,10H2,1H3
|
||||
InChIKey |
GGGHJXUDCCSXFE-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Estrogen receptor | Target Info | Inhibitor | [527327] | |
Pathway Interaction Database | Regulation of nuclear SMAD2/3 signaling | ||||
Signaling events mediated by HDAC Class II | |||||
Plasma membrane estrogen receptor signaling | |||||
LKB1 signaling events | |||||
Regulation of Telomerase | |||||
ATF-2 transcription factor network | |||||
AP-1 transcription factor network | |||||
FOXM1 transcription factor network | |||||
Validated nuclear estrogen receptor alpha network | |||||
Signaling mediated by p38-alpha and p38-beta | |||||
FOXA1 transcription factor network | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.